-
1
المؤلفون: BJ Krause, Martin Heuschkel, T Heller, SM Schwarzenböck, G Lamprecht, J Kurth
المصدر: 59. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::caf7982cdbfa0dbfafa16f43281538c0
https://doi.org/10.1055/s-0041-1727077 -
2
المؤلفون: J Kurth, BJ Krause, SM Schwarzenböck, Martin Heuschkel
المصدر: 59. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0e474d68bbca4daa311646e7601cc5c7
https://doi.org/10.1055/s-0041-1726712 -
3
المؤلفون: J Kurth, BJ Krause, HS Willenberg, SM Schwarzenböck, Martin Heuschkel, S Nitsch
المصدر: 58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::328330c02a1690ca84a8fd5ba4b74c60
https://doi.org/10.1055/s-0040-1708344 -
4
المؤلفون: R Schwarz, S Sender, Brigitte Vollmar, Anahit Pews-Davtyan, BJ Krause, SM Schwarzenböck, Hugo Murua Escobar, C Junghanß, M Guliyev, A Moeller, A Velicu, C Schlie, M Joksch, D Zechner, Matthias Beller, Tobias Lindner, Jan Stenzel, B Hinz, C Bergner, J Förster
المصدر: 58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Prostate cancer, business.industry, Internal medicine, medicine, medicine.disease, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::468e67ee25d9e12782770c428db877fb
https://doi.org/10.1055/s-0040-1708319 -
5
المؤلفون: BJ Krause, SM Schwarzenböck, OW Hakenberg, Martin Heuschkel, J Kurth, S Nitsch
المصدر: 57. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3026eed9e0d0e6e4bc67e1c4c6123ee3
https://doi.org/10.1055/s-0039-1683484 -
6
المؤلفون: J Kurth, BJ Krause, J Kretzschmar, SM Schwarzenböck, G Kundt, OW Hakenberg, Martin Heuschkel
المصدر: 57. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Prostate cancer, Therapy response, business.industry, Internal medicine, Targeted radionuclide therapy, medicine, In patient, Castration resistant, Psma pet ct, medicine.disease, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3dc48f7b8ef7b373e282538164c0591d
https://doi.org/10.1055/s-0039-1683739 -
7دورية أكاديمية
عنوان ترانسليتريتد: Einfluss der 68Ga-PSMA-PET/CT auf die Bestrahlungsplanung beim Prostatakarzinom.
المؤلفون: Bock F; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Frerker B; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Schubert L; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Rennau H; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Kurth J; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Krause BJ; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Hildebrandt G; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Schwarzenböck SM; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.
المصدر: Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2024 Jun; Vol. 63 (3), pp. 199-206. Date of Electronic Publication: 2024 Apr 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Thieme Country of Publication: Germany NLM ID: 7609387 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-6407 (Electronic) Linking ISSN: 00295566 NLM ISO Abbreviation: Nuklearmedizin Subsets: MEDLINE
مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography* , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/diagnostic imaging , Prostatic Neoplasms*/pathology , Gallium Radioisotopes* , Gallium Isotopes* , Radiotherapy Planning, Computer-Assisted*/methods , Edetic Acid*/analogs & derivatives , Oligopeptides*, Humans ; Male ; Aged ; Middle Aged ; Aged, 80 and over ; Radiopharmaceuticals/therapeutic use ; Treatment Outcome
-
8دورية أكاديمية
المؤلفون: Krönert MIC; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, 18057 Rostock, Germany., Schwarzenböck SM; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Kurth J; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Heuschkel M; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Krause BJ; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Emmert S; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, 18057 Rostock, Germany., Tietze JK; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, 18057 Rostock, Germany.
المصدر: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2024 Apr 29; Vol. 12 (9). Date of Electronic Publication: 2024 Apr 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101666525 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9032 (Print) Linking ISSN: 22279032 NLM ISO Abbreviation: Healthcare (Basel) Subsets: PubMed not MEDLINE
-
9دورية أكاديمية
المؤلفون: Djaïleb L; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: ldjaileb@chu-grenoble.fr., Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; ULCA-Caltech Medical Scientist Training Program, David Geffen School of Medicine, Los Angeles, CA, USA., Thompson D; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Gafita A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Farolfi A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rajagopal A; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Grogan TR; Department of Medicine Statistics Core, University of California Los Angeles, Los Angeles, CA, USA., Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Benz MR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA, USA., Hotta M; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Barbato F; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Schwarzenböck SM; Department of Nuclear Medicine, University Medical Centre, Rostock, Germany., Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Zacho HD; Department of Nuclear Medicine and Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark., Juarez R; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Cooperberg M; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Carroll P; Department of Urology, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Washington S; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Reiter RE; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Eiber M; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
المصدر: European urology [Eur Urol] 2023 Dec; Vol. 84 (6), pp. 588-596. Date of Electronic Publication: 2023 Jul 21.
نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
-
10دورية أكاديمية
المؤلفون: Tietze JK; From the Clinic and Policlinic for Dermatology and Venereology., Heuschkel M; Department of Nuclear Medicine, University Medical Center Rostock, Rostock, Germany., Krönert MIC; From the Clinic and Policlinic for Dermatology and Venereology., Kurth J; Department of Nuclear Medicine, University Medical Center Rostock, Rostock, Germany., Bandow G; From the Clinic and Policlinic for Dermatology and Venereology., Ojak G; From the Clinic and Policlinic for Dermatology and Venereology., Grünwald P; From the Clinic and Policlinic for Dermatology and Venereology., Herold JI; From the Clinic and Policlinic for Dermatology and Venereology., Thiem A; From the Clinic and Policlinic for Dermatology and Venereology., Dreßler M; From the Clinic and Policlinic for Dermatology and Venereology., Krause BJ; Department of Nuclear Medicine, University Medical Center Rostock, Rostock, Germany., Emmert S; From the Clinic and Policlinic for Dermatology and Venereology., Schwarzenböck SM; Department of Nuclear Medicine, University Medical Center Rostock, Rostock, Germany.
المصدر: Clinical nuclear medicine [Clin Nucl Med] 2023 Oct 01; Vol. 48 (10), pp. 869-876.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE
مواضيع طبية MeSH: Rhenium* , Skin Neoplasms*/radiotherapy, Humans ; Radioisotopes ; Pilot Projects ; Radiation, Ionizing